Tumor targeting dual stimuli responsive controllable release nanoplatform based on DNA-conjugated reduced graphene oxide for chemo-photothermal synergetic cancer therapy-Reference-Cited by-同舟云学术

Tumor targeting dual stimuli responsive controllable release nanoplatform based on DNA-conjugated reduced graphene oxide for chemo-photothermal synergetic cancer therapy

Published:2018 Issue:26 Volume:6 Page:4360-4367
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Jiang Wenjing¹²³⁴⁵,Mo Fan¹²³⁴⁵,Lin Yaohui¹²³⁴⁵,Wang Xusheng¹²³⁴⁵,Xu LiangJun¹²³⁴⁵,Fu FengFu¹²³⁴⁵^ORCID

Affiliation:

1. Key Laboratory for Analytical Science of Food Safety and Biology of MOE

2. Fujian Provincial Key Laboratory of Analysis and Detection for Food Safety

3. College of Chemistry

4. Fuzhou University

5. Fuzhou

Abstract

A tumor targeting dual stimuli responsive controllable release drug delivery nanoplatform was fabricated for chemo-photothermal synergetic cancer therapy based on DNA-conjugated reduced graphene oxide.

Funder

National Natural Science Foundation of China

Department of Education, Fujian Province

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2018/TB/C8TB00670A

Reference40 articles.

1. MSN Anti-Cancer Nanomedicines: Chemotherapy Enhancement, Overcoming of Drug Resistance, and Metastasis Inhibition

2. Versatile Triggered Release of Multiple Molecules from Cyclodextrin-Modified Gold-Gated Mesoporous Silica Nanocontainers